New User:

Forgot your password?

Stock Market & Financial Investment News

News For AMRN;WHX;TIVO;DGIT;VHC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 25, 2014
18:18 EDTTIVOOn The Fly: After Hours Movers
Subscribe for More Information
16:05 EDTTIVOTiVo sees Q4 service and technology revenues $87M-$90M
Subscribe for More Information
16:04 EDTTIVOTiVo reports Q3 EPS with expense 6c, consensus 7c
Subscribe for More Information
15:31 EDTTIVONotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Hewlett-Packard (HPQ), consensus $1.06; Analog Devices (ADI), consensus 68c; Cubic (CUB), consensus 94c; Nimble Storage (NMBL), consensus (16c); Veeva Systems (VEEV), consensus 8c; Infoblox (BLOX), consensus 3c; TiVo (TIVO), consensus 7c; Perfect World (PWRD), consensus 40c.
November 24, 2014
10:24 EDTTIVOHigh option volume stocks
08:23 EDTTIVOTiVo has favorable risk/reward amid 'TV Everywhere' shift, says Brean Capital
Brean Capital sees TiVo having a favorable risk/reward profile and believes the company is well positioned for a broad-based shift to TV Everywhere. The firm sees that shift resulting in new distribution, which will expand TiVo's subscription base and drive upside in its share price. Brean Capital reiterates its Buy rating and $16 price target on TiVo.
November 21, 2014
06:10 EDTTIVOTiVo November volatility elevated into Q3 and outlook
Subscribe for More Information
November 20, 2014
11:49 EDTVHCVirnetX updates licensing declarations to ETSI, ATIS
Subscribe for More Information
November 19, 2014
15:00 EDTAMRNStonepine Capital reports 5.2% passive stake in Amarin
November 17, 2014
09:06 EDTAMRNAmarin reports new data from MARINE, ANCHOR phase 3 studies
Amarin announced the presentation of new data and related analyses from the MARINE and ANCHOR phase 3 studies. The data show that use of Vascepa capsules significantly reduced remnant-like particle cholesterol, or RLP-C, levels -- a cardiovascular risk factor -- including significant placebo-adjusted reductions in RLP-C in studied patient populations with triglyceride, or TG, levels greater than or equal to 200 mg/dL and greater than or equal to 500 mg/dL, including patients that received statin therapy. The data were presented today by Dr. Christie M. Ballantyne as part of a moderated poster session at the American Heart Association Scientific Sessions in Chicago. Remnant-like particle cholesterol is an important emerging risk factor for cardiovascular disease and represents the cholesterol content of a subset of triglyceride-rich lipoproteins, or TRL, called remnants. In the fasting state this subset of TRLs is comprised of very low-density lipoproteins, or VLDL, and intermediate-density lipoproteins, or IDL, and in the non-fasting state includes these two types of lipoproteins together with chylomicron remnants.Elevated plasma TG levels are a marker of elevated remnant cholesterol and are associated with increased risk for cardiovascular disease.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use